Epidemiology of ADHD

Author/s
Luis A. Rohde, Rachel E. Verin, Guilherme V. Polanczyk
Citation
Issue 2 Spring 2012
CEPiP.2012.1.6-9
https://doi.org/10.65031/hwat7461
Abstract

In this selective review of the literature, we present recent data on the epidemiology of Attention Deficit Hyperactivity Disorder (ADHD) across the life-cycle. The worldwide ADHD prevalence rates are around 5.3% in children and adolescents and 2.5% in adults. The literature suggests that 40 – 60% of affected children continue having the disorder during adulthood, depending on the criteria for persistence applied. Demographic correlates such as gender, socio-economic stratum and ethnicity impact on prevalence rates in the community. There are clear barriers for treatment access even in developed countries.

Keywords
ADHD, hyperkinetic disorder, prevalence, epidemiology
References
  1. Kieling R, Rohde LA. ADHD in children and adults: Diagnosis and Prognosis. Curr Top Behav Neurosci 2011 Apr 16.            
  2. World Health Organization. The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. Geneva: WHO; 1993. 
  3. American Psychiatric Association, 2000. Diagnostic and Statistical Manual of Mental Disorders (4th edition, Text Revision) (DSM-IV-TR). Washington, DC: American Psychiatric Association. https://doi.org/10.1176/appi.books.9780890423349 https://doi.org/10.1176/appi.books.9780890423349
  4. Rohde LA. Is there a need to reformulate ADHD criteria in future classification systems? Child Adolesc Psychiatric Clin N Am 2008; 17(2):405-20.
  5. Polanczyk G, Rohde L A. Epidemiology of Attention-Deficit / Hyperactivity Disorder across the lifespan. Curr Opin Psychiatry 2007;20(4):386-92. https://doi.org/10.1097/yco.0b013e3281568d7a
  6. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The Worldwide Prevalence of ADHD: A Systematic Review and Meta-regression Analysis. Am J Psychiatry 2007;164, 942-948. https://doi.org/10.1176/ajp.2007.164.6.942
  7. Merikangas KR, He JP, Brody D, Fisher PW, Bourdon K, Koretz DS. Prevalence and Treatment of Mental Disorders Among US Children in the 2001 -2004 NHANES. Pediatrics 2010;125;75-81. https://doi.org/10.1542/peds.2008-2598
  8. Merikangas KR, He JP, Burstein M, Swanson SA, Avenevoli S, Cui L, Benjet C, Georgiades K, Swendsen J. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication - Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry 2010;49 (10):980-9. https://doi.org/10.1016/j.jaac.2010.05.017
  9. Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, De Girolamo G, Haro JM, Karam EG, Lara C, Lépine JP, Ormel J, Posada-Villa J, Zaslavsky AM, Jin R. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 2007;190, 402-409. https://doi.org/10.1192/bjp.bp.106.034389
  10. Simon V, Czobor P, Bálint S, Mészáros A, Bitter I. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry 2009;194:204-211. https://doi.org/10.1192/bjp.bp.107.048827
  11. Bernardi S, Faraone SV, Cortese S, Kerridge S, Pallanti S, Wang S, Blanco C. The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Psychol Med 2011. https://doi.org/10.1017/s003329171100153x
  12. Faraone SV, Biederman J, Mick E: The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med 2006, 36:159-65. https://doi.org/10.1017/s003329170500471x
  13. Larsson H, Dilshad R, Lichtenstein P, Barker ED. Developmental trajectories of DSM-IV symptoms of attention-deficit/ hyperactivity disorder: genetic effects, family risk and associated psychopathology. J Child Psychol Psychiatry. 2011;52(9):954-63. https://doi.org/10.1111/j.1469-7610.2011.02379.x
  14. Weiss G, Hechtman L, Milroy T, Perlman T: Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children. J Am Acad Child Adolesc Psychiatry 1985; 24: 211-220. https://doi.org/10.1016/s0002-7138(09)60450-7
  15. Kessler RC, Adler LA, Barkley R et al.: Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biol Psychiatry 2005, 57:1442-51. https://doi.org/10.1016/j.biopsych.2005.04.001
  16. Miller TW, Nigg JT, Miller RL Attention deficit hyperactivity disorder in African American children: what can be concluded from the past ten years? Clin Psychol Rev. 2009;29(1):77-86. https://doi.org/10.1016/j.cpr.2008.10.001
  17. Singh I. Beyond polemics: science and ethics of ADHD. Nature Rev 2008; 9: 957-964. https://doi.org/10.1038/nrn2514
  18. Polanczyk G, Rohde LA, Szobot C, Schmitz M, Montiel-Nava C, Bauermeister JJ. Treatment of ADHD in Latin America and the Caribbean. J Am Acad Child Adol Psychiatry 2008; 47(6):721-722. https://doi.org/10.1097/chi.0b013e31816c0008
  19. Sayal K, Ford T, Goodman R. Trends in recognition of and service use for attention-deficit hyperactivity disorder in Britain, 1999-2004. Psychiatr Serv 2010;61(8):803-10. https://doi.org/10.1176/ps.2010.61.8.803